A heart attack and broken heart syndrome share similar symptoms But the two are separate conditions requiring distinct ...

AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization to RINVOQ� (upadacitinib; 15 mg, once daily) for the treatment of giant cell arteritis (GCA) in ...

The interplay between aging and cellular senescence reveals insights into chronic inflammation and potential strategies for ...

It’s our favourite caffeine fix, but your morning pick-me-up could be impacting your body in unexpected ways, from hair and ...

Citing diabetes as the fourth leading cause of death and affecting approximately 4.4 million Filipinos, the researchers led by Assistant Professor Raymond Fernando Yu aims "to provide a locally ...

STRING analysis of 60 significant genes in CHD. Genes not previously implicated in human CHD that have at least one edge are denoted by red star ...

New Analyses Related to Aficamten Expand on its Metabolism Pathways, Treatment Effect Associated with Combination Therapy with Disopyramide and Longer-Term Effect on Cardiac Structure ... by the ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Aminotransferases ALT and AST, critical for amino acid metabolism, are mainly found in hepatocytes but also exist in renal, cardiac ... lead to insufficient enzyme release, resulting in decreased ...

The press release is available on our website at ... that 80% of patients who received the pivotal dose discontinued enzyme replacement therapy or remain treatment naïve as well as neuro ...